JFG
DGX icon

Jefferies Financial Group’s Quest Diagnostics DGX Stock Holding History

Jefferies Financial Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.68M Sell
17,375
-16,098
-48% -$3.16M 0.02% 467
2026
Q1 		$6.56M Sell
33,473
-7,646
-19% -$1.49M 0.04% 288
2025
Q4 		$7.14M Buy
41,119
+19,683
+92% +$3.58M 0.04% 409
2025
Q3 		$4.09M Sell
21,436
-4,024
-16% -$714K 0.02% 430
2025
Q2 		$4.57M Sell
25,460
-141
-0.6% -$24.5K 0.04% 322
2025
Q1 		$4.33M Buy
25,601
+701
+3% +$115K 0.04% 331
2024
Q4 		$3.76M Buy
24,900
+3,627
+17% +$564K 0.02% 454
2024
Q3 		$3.3M Sell
21,273
-38,032
-64% -$5.68M 0.02% 427
2024
Q2 		$8.12M Buy
59,305
+3,307
+6% +$453K 0.09% 184
2024
Q1 		$7.45M Buy
55,998
+49,198
+724% +$6.38M 0.07% 210
2023
Q4 		$938K Sell
6,800
-2,400
-26% -$316K 0.01% 988
2023
Q3 		$1.12M Buy
9,200
+5,854
+175% +$780K 0.01% 793
2023
Q2 		$470K Buy
+3,346
New +$461K ﹤0.01% 1196
2023
Q1 		– Sell
-5,170
Closed -$809K – 1704
2022
Q4 		$809K Buy
+5,170
New +$743K 0.01% 925

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Jefferies Financial Group's DGX Position: Q2 2026 in Review

Jefferies Financial Group reduced its Quest Diagnostics (DGX) stake by 48% in Q2 2026, selling an estimated $3.16M and leaving 17,375 shares worth $3.68M. The position accounts for 0.02% of the portfolio, ranked #467.

Jefferies Financial Group first reported a position in DGX in Q4 2022 and has held it in 14 quarters since. The position peaked at $8.12M in Q2 2024. 1,111 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Jefferies Financial Group held 17,375 shares of Quest Diagnostics worth $3.68M as of Q2 2026.
  • Jefferies Financial Group sold 16,098 Quest Diagnostics shares in Q2 2026, an estimated $3.16M.
  • Quest Diagnostics made up 0.02% of Jefferies Financial Group's portfolio in Q2 2026, its #467 holding.
  • Jefferies Financial Group first reported a position in Quest Diagnostics in Q4 2022 and has held it in 14 quarters since.
  • Jefferies Financial Group's Quest Diagnostics position peaked at $8.12M in Q2 2024.
  • 1,111 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.